Skip to main content
Premium Trial:

Request an Annual Quote

Gates Foundation Awards Opko $1M for TB MDx Development

NEW YORK (GenomeWeb News) – Opko Health has received a $1 million grant from the Bill and Melinda Gates Foundation for the development of a tuberculosis test, the company announced today.

The grant will support development of a test for distinguishing latent TB from active TB using Opko's molecular diagnostics technology. The Miami-based firm also leverages the technology to create blood-based tests for identifying biomarkers for diseases including neurodegenerative disorders and malignancies.

Opko is a pharmaceutical and diagnostic firm. Its molecular diagnostics platform was developed in the laboratory of Thomas Kodadek at the Scripps Research Institute and is based on immunoglobulin autoantibodies as disease-specific biomarkers, the company said on its website.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.